Published in J Bacteriol on April 01, 1999
Recognition of misfolded proteins by Lon, a AAA(+) protease. Genes Dev (2008) 1.77
Forespore-specific transcription of the lonB gene during sporulation in Bacillus subtilis. J Bacteriol (2001) 1.07
A membrane-bound archaeal Lon protease displays ATP-independent proteolytic activity towards unfolded proteins and ATP-dependent activity for folded proteins. J Bacteriol (2002) 1.05
Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine. Infect Immun (2010) 1.04
Slicing a protease: structural features of the ATP-dependent Lon proteases gleaned from investigations of isolated domains. Protein Sci (2006) 1.03
Lon protease influences antibiotic production and UV tolerance of Pseudomonas fluorescens Pf-5. Appl Environ Microbiol (2000) 0.93
Structure of the N-terminal fragment of Escherichia coli Lon protease. Acta Crystallogr D Biol Crystallogr (2010) 0.83
Biological roles of the Podospora anserina mitochondrial Lon protease and the importance of its N-domain. PLoS One (2012) 0.83
Roles of the N domain of the AAA+ Lon protease in substrate recognition, allosteric regulation and chaperone activity. Mol Microbiol (2013) 0.81
Binding and cleavage of E. coli HUbeta by the E. coli Lon protease. Biophys J (2010) 0.80
Characterization of three putative Lon proteases of Thermus thermophilus HB27 and use of their defective mutants as hosts for production of heterologous proteins. Extremophiles (2007) 0.80
Negative regulation of pathogenesis in Pseudomonas syringae pv. tabaci 11528 by ATP-dependent Lon protease. Mol Cells (2011) 0.77
Oxidization without substrate unfolding triggers proteolysis of the peroxide-sensor, PerR. Proc Natl Acad Sci U S A (2015) 0.77
A mutation in the N domain of Escherichia coli lon stabilizes dodecamers and selectively alters degradation of model substrates. J Bacteriol (2013) 0.76
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
Predicting coiled coils from protein sequences. Science (1991) 38.18
A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli. Microbiol Rev (1989) 15.19
A LOCUS THAT CONTROLS FILAMENT FORMATION AND SENSITIVITY TO RADIATION IN ESCHERICHIA COLI K-12. Genetics (1964) 11.90
An inducible DNA replication-cell division coupling mechanism in E. coli. Nature (1981) 6.89
Prophage induction and cell division in E. coli. III. Mutations sfiA and sfiB restore division in tif and lon strains and permit the expression of mutator properties of tif. Mol Gen Genet (1975) 6.82
Deg phenotype of Escherichia coli lon mutants. J Bacteriol (1978) 6.16
Prediction and analysis of coiled-coil structures. Methods Enzymol (1996) 5.74
Cell-division control in Escherichia coli: specific induction of the SOS function SfiA protein is sufficient to block septation. Proc Natl Acad Sci U S A (1984) 5.34
Mutants of Escherichia coli with a defect in the degradation of nonsense fragments. Nat New Biol (1973) 5.22
Proteases and their targets in Escherichia coli. Annu Rev Genet (1996) 5.08
Protein degradation in Escherichia coli: the lon gene controls the stability of sulA protein. Proc Natl Acad Sci U S A (1983) 5.06
REGULATORY MECHANISMS FOR SYNTHESIS OF CAPSULAR POLYSACCHARIDE IN MUCOID MUTANTS OF ESCHERICHIA COLI K12. Proc Natl Acad Sci U S A (1964) 5.03
Regulation by proteolysis: energy-dependent proteases and their targets. Microbiol Rev (1992) 4.83
The product of the lon (capR) gene in Escherichia coli is the ATP-dependent protease, protease La. Proc Natl Acad Sci U S A (1981) 4.10
Regulation of capsular polysaccharide synthesis in Escherichia coli K-12: characterization of three regulatory genes. J Bacteriol (1985) 4.01
Role of sulA and sulB in filamentation by lon mutants of Escherichia coli K-12. J Bacteriol (1981) 3.75
ATP hydrolysis-dependent protease activity of the lon (capR) protein of Escherichia coli K-12. Proc Natl Acad Sci U S A (1981) 3.61
Insertional mutagenesis of the lon gene in Escherichia coli: lon is dispensable. J Bacteriol (1985) 3.47
Role of the SulB (FtsZ) protein in division inhibition during the SOS response in Escherichia coli: FtsZ stabilizes the inhibitor SulA in maxicells. Proc Natl Acad Sci U S A (1985) 3.31
Capsule synthesis in Escherichia coli K-12 is regulated by proteolysis. J Bacteriol (1987) 3.30
lon transcriptional regulation of genes necessary for capsular polysaccharide synthesis in Escherichia coli K-12. J Bacteriol (1984) 3.26
RcsA, an unstable positive regulator of capsular polysaccharide synthesis. J Bacteriol (1991) 3.24
Sequence of the lon gene in Escherichia coli. A heat-shock gene which encodes the ATP-dependent protease La. J Biol Chem (1988) 3.21
Fine-structure mapping and identification of two regulators of capsule synthesis in Escherichia coli K-12. J Bacteriol (1988) 3.12
The mechanism and functions of ATP-dependent proteases in bacterial and animal cells. Eur J Biochem (1992) 3.12
Regulation of capsular polysaccharide synthesis in Escherichia coli K12. Mol Microbiol (1991) 2.89
A small RNA acts as an antisilencer of the H-NS-silenced rcsA gene of Escherichia coli. Proc Natl Acad Sci U S A (1995) 2.73
Genetics of proteolysis in Escherichia coli*. Annu Rev Genet (1989) 2.45
Overproduction of FtsZ suppresses sensitivity of lon mutants to division inhibition. J Bacteriol (1986) 2.44
Proteases and protein degradation in Escherichia coli. Experientia (1992) 2.25
Coiled-coils in alpha-helix-containing proteins: analysis of the residue types within the heptad repeat and the use of these data in the prediction of coiled-coils in other proteins. Biosci Rep (1982) 2.13
Further characterization of sfiA and sfiB mutations in Escherichia coli. J Bacteriol (1980) 2.01
Mutations in the Ion gene of E. coli K12 phenotypically suppress a mutation in the sigma subunit of RNA polymerase. Cell (1983) 1.74
Proteases in Escherichia coli. Methods Enzymol (1981) 1.72
A method for the efficient blotting of strongly basic proteins from sodium dodecyl sulfate-polyacrylamide gels to nitrocellulose. Anal Biochem (1985) 1.59
Selectivity of intracellular proteolysis: protein substrates activate the ATP-dependent protease (La). Science (1986) 1.57
Protease La from Escherichia coli hydrolyzes ATP and proteins in a linked fashion. Proc Natl Acad Sci U S A (1982) 1.57
Identification and purification of the Lon+ (capR+) gene product, a DNA-binding protein. Proc Natl Acad Sci U S A (1981) 1.53
Mutation blocking the specific degradation of reinitiation polypeptides in E. coli. Nature (1975) 1.51
An increased content of protease La, the lon gene product, increases protein degradation and blocks growth in Escherichia coli. J Biol Chem (1987) 1.38
Site-directed mutagenesis of La protease. A catalytically active serine residue. FEBS Lett (1991) 1.34
Protease La, the lon gene product, cleaves specific fluorogenic peptides in an ATP-dependent reaction. J Biol Chem (1985) 1.15
Alp, a suppressor of lon protease mutants in Escherichia coli. J Bacteriol (1989) 1.14
The role of ATP hydrolysis in the breakdown of proteins and peptides by protease La from Escherichia coli. J Biol Chem (1985) 1.14
Escherichia coli RcsA, a positive activator of colanic acid capsular polysaccharide synthesis, functions To activate its own expression. J Bacteriol (1999) 1.11
DNA stimulates ATP-dependent proteolysis and protein-dependent ATPase activity of protease La from Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.09
PinA inhibits ATP hydrolysis and energy-dependent protein degradation by Lon protease. J Biol Chem (1998) 1.03
Regulatory region of the heat shock-inducible capR (lon) gene: DNA and protein sequences. J Bacteriol (1985) 1.02
Mutations in the proteolytic domain of Escherichia coli protease Lon impair the ATPase activity of the enzyme. FEBS Lett (1998) 0.96
A bacteriophage T4 gene which functions to inhibit Escherichia coli Lon protease. J Bacteriol (1988) 0.96
An imbalance of HU synthesis induces mucoidy in Escherichia coli. J Mol Biol (1993) 0.94
Bacterial protease Lon is a site-specific DNA-binding protein. J Biol Chem (1997) 0.93
DNA-stimulated ATPase activity on the lon (CapR) protein. J Bacteriol (1984) 0.93
A point mutation within the ATP-binding site inactivates both catalytic functions of the ATP-dependent protease La (Lon) from Escherichia coli. FEBS Lett (1994) 0.91
Isolation and characterization of the phage T4 PinA protein, an inhibitor of the ATP-dependent lon protease of Escherichia coli. J Biol Chem (1998) 0.88
Saturation and specificity of the Lon protease of Escherichia coli. J Bacteriol (1990) 0.86
Identification of a second RcsA protein, a positive regulator of colanic acid capsular polysaccharide genes, in Escherichia coli. J Bacteriol (1996) 0.85
[Cloning, structure and expression of the full-size lon gene in Escherichia coli coding for ATP-dependent La-proteinase]. Bioorg Khim (1990) 0.81
Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11
Synthesis of sigma 29, an RNA polymerase specificity determinant, is a developmentally regulated event in Bacillus subtilis. J Bacteriol (1985) 3.97
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70
Bacillus subtilis sigma factor sigma 29 is the product of the sporulation-essential gene spoIIG. Proc Natl Acad Sci U S A (1985) 3.64
Sporulation-specific sigma factor sigma 29 of Bacillus subtilis is synthesized from a precursor protein, P31. Proc Natl Acad Sci U S A (1987) 3.34
Translocation as a species conservation tool: status and strategy. Science (1989) 3.31
Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69
Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet (1996) 2.53
Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52
Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol (1997) 2.40
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
Excision of a P4-like cryptic prophage leads to Alp protease expression in Escherichia coli. J Bacteriol (1994) 2.19
Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10
A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
Placental insufficiency and the small-for-dates baby. Am J Obstet Gynecol (1972) 1.72
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res (1997) 1.71
Status and prospects for success of the endangered species act: a look at recovery plans. Science (1993) 1.68
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
Characterization of the amyloid fibril as a cross-beta protein. Proc Soc Exp Biol Med (1969) 1.66
Crystal structure of rat liver dihydropteridine reductase. Proc Natl Acad Sci U S A (1992) 1.63
An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61
Isolation of Bacillus subtilis mutants altered in expression of a gene transcribed in vitro by a minor form of RNA polymerase (E-sigma 37). J Bacteriol (1985) 1.55
Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.55
Localisation of the vaso-motor centre. J Physiol (1923) 1.51
The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG (2000) 1.42
Cloning of a chromosomal gene required for phage infection of Lactococcus lactis subsp. lactis C2. J Bacteriol (1993) 1.41
Women and the GMC. Br Med J (Clin Res Ed) (1985) 1.38
Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet (1999) 1.37
The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun (1976) 1.34
Inactivation of mdoH leads to increased expression of colanic acid capsular polysaccharide in Escherichia coli. J Bacteriol (1997) 1.28
Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet (1981) 1.25
The part played by the ala cinerea in vaso-motor reflexes. J Physiol (1925) 1.25
Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther (2008) 1.21
Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM (1997) 1.21
Identification of a new vitamin B 12 binder (transcobalamin 3) in normal human serum. Br J Haematol (1972) 1.18
Use of beta-lactamase to hydrolyse interfering antibiotics in vitamin B12 microbiological assay using Lactobacillus leichmannii. Clin Lab Haematol (1990) 1.18
Homocysteine and cardiovascular risk. Am J Clin Nutr (2000) 1.13
Trouble-free microbiologic serum and red cell folate assays. Am J Med Technol (1974) 1.13
Mechanism of choline O-sulphate utilization in fungi. Biochem J (1968) 1.13
Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet (1997) 1.13
Betaine-homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clin Sci (Lond) (1991) 1.11
Escherichia coli RcsA, a positive activator of colanic acid capsular polysaccharide synthesis, functions To activate its own expression. J Bacteriol (1999) 1.11
Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem (1998) 1.10
Microbiological assay for vitamin B12 with use of a colistin-sulfate-resistant organism. Clin Chem (1987) 1.10
Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Gene Ther (2008) 1.10
A comparison of serum folate estimations using two different methods. J Clin Pathol (1973) 1.10
Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J Immunol (1991) 1.09
Oedema of the umbilical cord and respiratory distress in the newborn. Br J Obstet Gynaecol (1975) 1.08
Monozygous anencephalic triplets--a case report. J Obstet Gynaecol Br Commonw (1966) 1.04
Loss of ribosomal protein L11 blocks stress activation of the Bacillus subtilis transcription factor sigma(B). J Bacteriol (2001) 1.03
Drug-induced megaloblastic change. Clin Haematol (1980) 1.03
Effect of bile on vitamin B12 absorption. Br Med J (1980) 1.01
Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull (1999) 0.99
Studies on derivation of transcobalamin 3 from granulocytes. Enhancement by lithium and elimination by fluoride of in vitro increments in vitamin B12-binding capacity. J Clin Invest (1974) 0.99
The biochemical basis of the neuropathy in cobalamin deficiency. Baillieres Clin Haematol (1995) 0.98
Immunosuppression in bovine trypanosomiasis: field studies using foot-and-mouth disease vaccine and clostridial vaccine. Trop Anim Health Prod (1977) 0.98
Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr (2001) 0.98
Accelerated folate breakdown in pregnancy. Lancet (1993) 0.97
Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am J Med Genet (1998) 0.96
In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease. J Clin Invest (1990) 0.96
Human bone marrow biochemical function and megaloblastic hematopoiesis after nitrous oxide anesthesia. Anesthesiology (1981) 0.95
Methylation deficiency causes vitamin B12-associated neuropathy in the pig. J Neurochem (1988) 0.95
Folate metabolism, the enterohepatic circulation and alcohol. Biochem Pharmacol (1985) 0.94
Anaemia of pregnancy: the changing postwar pattern. Br Med J (1975) 0.94
Regulation of choline sulphatase synthesis and activity in Aspergillus nidulans. Biochem J (1968) 0.94
Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects. J Med Genet (2010) 0.93
Growth associated exopolysaccharide expression in Lactococcus lactis subspecies cremoris Ropy352. J Dairy Sci (2000) 0.93
Context dependence of mutational effects in a protein: the crystal structures of the V35I, I47V and V35I/I47V gene V protein core mutants. J Mol Biol (1996) 0.93
Plasma homocysteine is not subject to seasonal variation. Clin Chem (2001) 0.92
The identification of pteroylpentaglutamate as the major folate derivative in rat liver and the demonstration of its biosynthesis from exogenous ( 3 H) pteroylglutamate. Biochem Biophys Res Commun (1972) 0.92
The effect of ethanol on one-carbon metabolism: increased methionine catabolism and lipotrope methyl-group wastage. Hepatology (1993) 0.92
Two new serotypes of Pasteurella haemolytica from sheep in Ethiopia. Trop Anim Health Prod (1979) 0.92
Immunosuppression in bovine trypanosomiasis: studies with louping-ill vaccine. Res Vet Sci (1979) 0.92
Further studies on the umbilical cord and its water content. J Clin Pathol (1978) 0.91
Folate composition, synthesis and function in natural materials. Clin Haematol (1976) 0.91
A new high performance liquid chromatographic method for the simultaneous measurement of S-adenosylmethionine and S-adenosylhomocysteine. Concentrations in pig tissues after inactivation of methionine synthase by nitrous oxide. Biomed Chromatogr (1990) 0.91
Folates and prevention of disease. Public Health Nutr (2001) 0.91
Relative roles of signals upstream of AAUAAA and promoter proximity in regulation of human immunodeficiency virus type 1 mRNA 3' end formation. Mol Cell Biol (1992) 0.90
The absorption of the diastereoisomers of 5-methyltetrahydropteroylglutamate in man: a carrier-mediated process. Clin Sci Mol Med (1973) 0.89
Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age. QJM (2002) 0.89
The prevention of neural tube defects. Curr Opin Obstet Gynecol (1998) 0.88
Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. Arch Dis Child (1985) 0.88
Nutritional stability of various naturally occurring monoglutamate derivatives of folic acid. Am J Clin Nutr (1975) 0.88
Three-dimensional molar enamel distribution and thickness in Australopithecus and Paranthropus. Biol Lett (2008) 0.88
Erythrocyte, plasma, and serum folate: specimen stability before microbiological assay. Clin Chem (1980) 0.87
Folate and clefts of the lip and palate--a U.K.-based case-control study: Part II: Biochemical and genetic analysis. Cleft Palate Craniofac J (2007) 0.87
A case of listeriosis of the newborn. J Med Microbiol (1968) 0.87
The identification of the products of folate catabolism in the rat. Br J Haematol (1978) 0.87
Choline transport into rat liver mitochondria. Characterization and kinetics of a specific transporter. J Biol Chem (1992) 0.86
Homocysteine and neural tube defects. J Nutr (1996) 0.86
Thin-layer chromatography of pteroylglutamates and related compounds. Application to transport and metabolism of reduced folates in blood. J Chromatogr (1973) 0.86
Ingestion and absorption of naturally occurring pteroylmonoglutamates (folates) in man. Gastroenterology (1973) 0.85